metoprolol has been researched along with Hallucinations in 3 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
Hallucinations: Subjectively experienced sensations in the absence of an appropriate stimulus, but which are regarded by the individual as real. They may be of organic origin or associated with MENTAL DISORDERS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 71-year-old man had had visual hallucinations and vivid dreams for two years after starting to take metoprolol." | 7.76 | [Hallucinations and vivid dreams by use of metoprolol]. ( Ahmed, AI; Jansen, PA; van Mierlo, PJ; van Waarde, JA, 2010) |
| " The validity of this hypothesis was tested in a double-blind crossover study in which the hydrophilic beta-blocker atenolol was compared with the lipophilic agents metoprolol and propranolol, in 14 patients with a previous history of nightmares or hallucinations when treated with lipophilic beta-blockers." | 5.05 | Central nervous system side-effects with hydrophilic and lipophilic beta-blockers. ( Westerlund, A, 1985) |
| "A 71-year-old man had had visual hallucinations and vivid dreams for two years after starting to take metoprolol." | 3.76 | [Hallucinations and vivid dreams by use of metoprolol]. ( Ahmed, AI; Jansen, PA; van Mierlo, PJ; van Waarde, JA, 2010) |
| "Nocturnal urinary melatonin excretion was evaluated in six patients with nightmares and hallucinations during treatment with beta-adrenoceptor blocking agents, and compared to six control patients with similar diagnoses and treatment but without such symptoms from the central nervous system (CNS)." | 3.67 | Depressed melatonin secretion in patients with nightmares due to beta-adrenoceptor blocking drugs. ( Brismar, K; Mogensen, L; Wetterberg, L, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, AI | 1 |
| van Mierlo, PJ | 1 |
| van Waarde, JA | 1 |
| Jansen, PA | 1 |
| Westerlund, A | 1 |
| Brismar, K | 1 |
| Mogensen, L | 1 |
| Wetterberg, L | 1 |
1 trial available for metoprolol and Hallucinations
| Article | Year |
|---|---|
Central nervous system side-effects with hydrophilic and lipophilic beta-blockers.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Blood Pressure; Central Nervous System; Double-B | 1985 |
2 other studies available for metoprolol and Hallucinations
| Article | Year |
|---|---|
[Hallucinations and vivid dreams by use of metoprolol].
Topics: Adrenergic beta-Antagonists; Aged; Central Nervous System; Dreams; Hallucinations; Humans; Lipids; M | 2010 |
Depressed melatonin secretion in patients with nightmares due to beta-adrenoceptor blocking drugs.
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Atenolol; Dreams; Female; Hallucinations; Humans; Mal | 1987 |